Q: Which Doctor Should I Consult for River Blindness / Onchocerciasis? A: You should consult an infectious disease specialist for river blindness or onchocerciasis. A: Onchocerciasis is prevalent in ...

Looking for reliable medications to treat 'Onchocerciasis / River Blindness'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name ...

Onchocerciasis — commonly called river blindness — is a parasitic infection common in sub-Saharan Africa. It’s the second most common cause of infectious blindness globally. The World Health ...

Onchocerciasis, which is also known as river blindness, is an infectious condition of the skin and eyes that is caused by the parasitic worm Onchocerca volvulus. Onchocerciasis is transmitted by the ...

A report on onchocerciasis (also known as river blindness) shows continued global progress towards achieving interruption of transmission of the disease. Data captured during 2019 show that more than ...

Introduction Onchocerciasis, commonly known as river blindness, is a parasitic disease caused by Onchocerca volvulus affecting millions predominantly in sub-Saharan Africa. Robust epidemiological ...

The donation of ivermectin by Merck and Co. Inc. has led to one of the most effective private–public partnerships controlling a disease of major public health importance particularly in Africa. The up ...

This press release is also available in Spanish. Onchocerciasis, river blindness or craw craw is an endemic disease in Bioko Island, Equatorial Guinea. This pathology causes a weakening in affected ...

Mr Michael Igbe, the Programme Manager, National Onchocerciasis Elimination Programme, Federal Ministry of Health, says about 50 million Nigerians are at risk of getting infected with onchocerciasis, ...

Researchers from LSTM and the University of Liverpool have successfully optimized a hit from a whole cell screening of a 10000-compound library to deliver the first novel fully synthetic and ...

The Neglected Tropical Diseases (NTDs) Programme of the Ghana Health Service (GHS) will from August 23 to September 6, 2021, begin a Mass Drug Administration (MDA) for onchocerciasis in endemic ...